Carl R. Iberger
2019
In 2019, Carl R. Iberger earned a total compensation of $244.7K as Chief Financial Officer at Transgenomic, a 39% decrease compared to previous year.
Compensation breakdown
| Option Awards | $34,000 |
|---|---|
| Salary | $200,000 |
| Other | $10,671 |
| Total | $244,671 |
Iberger received $200K in salary, accounting for 82% of the total pay in 2019.
Iberger also received $34K in option awards and $10.7K in other compensation.
Rankings
In 2019, Carl R. Iberger's compensation ranked 13,253rd out of 13,971 executives tracked by ExecPay. In other words, Iberger earned more than 5.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,253 out of 13,971 | 5th |
Division Manufacturing | 5,392 out of 5,695 | 5th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 781 out of 832 | 6th |
Industry group Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments | 216 out of 229 | 6th |
Industry Laboratory Analytical Instruments | 64 out of 69 | 7th |
Source: SEC filing on April 29, 2020.
Iberger's colleagues
We found three more compensation records of executives who worked with Carl R. Iberger at Transgenomic in 2019.